RELATED: Wegovy alternatives The warning indicates that GLP-1 agonists have been linked to thyroid tumors in animal clinical trials
You could also qualify with a BMI of 27 kg/m2 or higher, if you have risk factors for cardiovascular disease such as hypertension (high blood pressure), high cholesterol, hyperlipidaemia (high levels of fats in the blood), fatty liver disease or obstructive sleep apnoea
Historical Context The development of GLP-1 receptor agonists, which are synthetic versions of the hormone, has transformed the landscape of weight management and diabetes treatment
Sources SURMOUNT-5 head-to-head results (Lilly): SURMOUNT-5 NEJM coverage (Pharmacy Times): LillyDirect Zepbound self-pay vials: Lilly Zepbound pricing: SURMOUNT-1, SURMOUNT-3, SURMOUNT-4 trial data: auto-rendered in the page citation panel Ready to try tirzepatide
Frequently Asked Questions Will I regain all my weight if I stop taking GLP-1
This has led to a surge in demand fueled by both social media influencers and celebrities sharing their remarkable Ozempic weight loss experiences
.png)
